SMMT logo

Summit Therapeutics (SMMT) Selling, General & Administrative Expenses

Annual SGA

$30.30 M
+$3.60 M+13.48%

December 31, 2023

Summary

Performance

1-Year Change

+13.48%

3-Year Change

+57.81%

5-Year Change

+78.09%

15-Year Change

+120.93%

SMMT SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

50.89%
SMMT annual SGA is higher than 50.89% of companies in Healthcare sector

High & Low

All-time High

$30.30 M
SMMT annual SGA is currently at an all-time high

3-Year Low

$23.60 M
SMMT annual SGA is currently +28.39% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
SMMT previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 20, 2025
SMMT next annual earnings announcement is scheduled for Feb 20, 2025

OtherSMMTexpensesmetrics:

Annual Total Expenses

$88.77 M
SMMT annual total expenses is $88.77 million

Annual Operating Expenses

$88.77 M
SMMT annual total operating expenses is $88.77 million

Annual Cost Of Goods Sold

-
SMMT annual cost of goods sold value is unknown

Annual Interest Expense

$16.46 M
SMMT annual interest expense is $16.46 million

Quarterly SGA

$20.39 M
+$6.42 M+45.95%

September 30, 2024

Summary

Performance

3-Month Change

+45.95%

1-Year Change

+45.95%

3-Year Change

+170.6%

5-Year Change

+261.93%

SMMT Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

68.32%
SMMT quarterly SGA is higher than 68.32% of companies in Healthcare sector

High & Low

All-time High

$20.39 M
SMMT quarterly SGA is currently at an all-time high

3-Year Low

$5.43 M
SMMT quarterly SGA is currently +275.23% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
SMMT previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 20, 2025
SMMT next earnings announcement is scheduled for Feb 20, 2025

OtherSMMTexpensesmetrics:

Quarterly Total Expenses

$58.38 M
SMMT quarterly total expenses is $58.38 million

Quarterly Operating Expenses

$58.38 M
SMMT quarterly total operating expenses is $58.38 million

Quarterly Cost Of Goods Sold

-
SMMT quarterly cost of goods sold value is unknown

Quarterly Interest Expense

$2.46 M
SMMT quarterly interest expense is $2.46 million

TTM SGA

-$4.28 B
-$196.68 M-4.82%

September 30, 2024

Summary

Performance

3-Month Change

-10114.21%

1-Year Change

-10114.21%

3-Year Change

-16131.74%

5-Year Change

-29779.76%

SMMT TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

9.3%
SMMT TTM SGA is higher than 9.3% of companies in Healthcare sector

High & Low

All-time High

-$215.00 K

3-Year Low

-$4.28 B
SMMT TTM SGA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
SMMT previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 20, 2025
SMMT next earnings announcement is scheduled for Feb 20, 2025

OtherSMMTexpensesmetrics:

Annual Total Expenses

$88.77 M
SMMT annual total expenses is $88.77 million

Annual Operating Expenses

$88.77 M
SMMT annual total operating expenses is $88.77 million

TTM Cost Of Goods Sold

-
SMMT TTM cost of goods sold value is unknown

TTM Interest Expense

$11.57 M
SMMT TTM interest expense is $11.57 million

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

Annual SGA

$30.30 M
SMMT annual SGA is $30.30 million

Annual Operating Expenses

$88.77 M
SMMT annual total operating expenses is $88.77 million

Annual Cost Of Goods Sold

-
SMMT annual cost of goods sold value is unknown

SMMT Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+13.5%+46.0%-10000.0%
3 y3 years+57.8%+170.6%-10000.0%
5 y5 years+78.1%+261.9%-10000.0%

SMMT Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+28.4%at high+275.2%-304.2%at low
5 y5-yearat high+168.6%at high+577.9%-1185.5%at low
alltimeall timeat high>+9999.0%at high+3491.7%<-9999.0%at low

Summit Therapeutics Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2024
-
$20.39 M(+45.9%)
$57.70 M(+35.0%)
Jun 2024
-
$13.97 M(+19.1%)
$42.74 M(+21.8%)
Mar 2024
-
$11.73 M(+1.0%)
$35.09 M(+15.8%)
Dec 2023
$30.30 M(+13.5%)
$11.61 M(+113.7%)
$30.30 M(+15.5%)
Sep 2023
-
$5.43 M(-14.0%)
$26.23 M(-0.5%)
Jun 2023
-
$6.32 M(-9.0%)
$26.36 M(-2.3%)
Mar 2023
-
$6.94 M(-7.9%)
$26.98 M(+1.1%)
Dec 2022
$26.70 M(+13.1%)
$7.54 M(+35.2%)
$26.70 M(-0.9%)
Sep 2022
-
$5.57 M(-19.6%)
$26.93 M(-0.3%)
Jun 2022
-
$6.93 M(+4.1%)
$27.02 M(+3.6%)
Mar 2022
-
$6.66 M(-14.3%)
$26.07 M(+10.5%)
Dec 2021
$23.60 M(+22.9%)
$7.77 M(+37.2%)
$23.60 M(+25.3%)
Sep 2021
-
$5.66 M(-5.4%)
$18.84 M(-5.9%)
Jun 2021
-
$5.98 M(+43.0%)
$20.02 M(+1.1%)
Mar 2021
-
$4.18 M(+39.1%)
$19.81 M(+3.2%)
Dec 2020
$19.20 M(+70.2%)
-
-
Dec 2020
-
$3.01 M(-56.1%)
$19.20 M(+18.6%)
Sep 2020
-
$6.85 M(+18.6%)
$16.19 M(+8.1%)
Jun 2020
-
$5.77 M(+61.6%)
$14.98 M(+40.4%)
Mar 2020
-
$3.57 M(-36.6%)
$10.67 M(-26.0%)
Dec 2019
$11.28 M(-33.7%)
-
-
Oct 2019
-
$5.63 M(+284.8%)
$14.42 M(-1.9%)
Jul 2019
-
$1.46 M(-31.6%)
$14.70 M(-9.8%)
Apr 2019
-
$2.14 M(-58.7%)
$16.30 M(-6.1%)
Jan 2019
$17.01 M(+24.1%)
-
-
Jan 2019
-
$5.18 M(-12.3%)
$17.36 M(+3.5%)
Oct 2018
-
$5.91 M(+93.5%)
$16.77 M(+24.5%)
Jul 2018
-
$3.06 M(-4.6%)
$13.47 M(-1.6%)
Apr 2018
-
$3.21 M(-30.2%)
$13.69 M(+0.4%)
Jan 2018
$13.71 M
-
-
DateAnnualQuarterlyTTM
Jan 2018
-
$4.59 M(+75.6%)
$13.63 M(+11.3%)
Oct 2017
-
$2.62 M(-20.0%)
$12.24 M(+2.4%)
Jul 2017
-
$3.27 M(+3.9%)
$11.95 M(+6.7%)
Apr 2017
-
$3.15 M(-1.9%)
$11.21 M(+10.4%)
Jan 2017
$9.62 M(+41.6%)
-
-
Jan 2017
-
$3.21 M(+37.9%)
$10.15 M(+19.1%)
Oct 2016
-
$2.33 M(-7.8%)
$8.53 M(+3.9%)
Jul 2016
-
$2.52 M(+20.6%)
$8.21 M(+13.3%)
Apr 2016
-
$2.09 M(+32.2%)
$7.25 M(+6.4%)
Jan 2016
$6.79 M(+21.8%)
-
-
Jan 2016
-
$1.58 M(-21.1%)
$6.81 M(+17.5%)
Oct 2015
-
$2.01 M(+28.4%)
$5.80 M(+20.5%)
Jul 2015
-
$1.56 M(-5.7%)
$4.81 M(-19.1%)
Apr 2015
-
$1.66 M(+192.1%)
$5.95 M(+2.5%)
Jan 2015
$5.58 M(+74.2%)
-
-
Jan 2015
-
$567.70 K(-44.5%)
$5.80 M(-8.2%)
Oct 2014
-
$1.02 M(-62.1%)
$6.32 M(+3.2%)
Jul 2014
-
$2.70 M(+78.7%)
$6.13 M(+78.8%)
Apr 2014
-
$1.51 M(+38.8%)
$3.42 M(+78.9%)
Jan 2014
$3.20 M(+20.1%)
-
-
Jan 2014
-
$1.09 M(+31.7%)
$1.91 M(+131.7%)
Oct 2013
-
$826.00 K
$826.00 K
Jan 2013
$2.67 M(+10.5%)
-
-
Jan 2012
$2.41 M(+685.7%)
-
-
Jan 2011
$307.00 K(-59.0%)
-
-
Jan 2010
$749.30 K(-33.3%)
-
-
Jan 2009
$1.12 M(-48.2%)
-
-
Jan 2008
$2.17 M(+116.9%)
-
-
Jan 2007
$1.00 M(+90.6%)
-
-
Jan 2006
$524.80 K(+895.8%)
-
-
Jan 2005
$52.70 K
-
-

FAQ

  • What is Summit Therapeutics annual SGA?
  • What is the all time high annual SGA for Summit Therapeutics?
  • What is Summit Therapeutics annual SGA year-on-year change?
  • What is Summit Therapeutics quarterly SGA?
  • What is the all time high quarterly SGA for Summit Therapeutics?
  • What is Summit Therapeutics quarterly SGA year-on-year change?
  • What is Summit Therapeutics TTM SGA?
  • What is the all time high TTM SGA for Summit Therapeutics?
  • What is Summit Therapeutics TTM SGA year-on-year change?

What is Summit Therapeutics annual SGA?

The current annual SGA of SMMT is $30.30 M

What is the all time high annual SGA for Summit Therapeutics?

Summit Therapeutics all-time high annual SGA is $30.30 M

What is Summit Therapeutics annual SGA year-on-year change?

Over the past year, SMMT annual SGA has changed by +$3.60 M (+13.48%)

What is Summit Therapeutics quarterly SGA?

The current quarterly SGA of SMMT is $20.39 M

What is the all time high quarterly SGA for Summit Therapeutics?

Summit Therapeutics all-time high quarterly SGA is $20.39 M

What is Summit Therapeutics quarterly SGA year-on-year change?

Over the past year, SMMT quarterly SGA has changed by +$6.42 M (+45.95%)

What is Summit Therapeutics TTM SGA?

The current TTM SGA of SMMT is -$4.28 B

What is the all time high TTM SGA for Summit Therapeutics?

Summit Therapeutics all-time high TTM SGA is -$215.00 K

What is Summit Therapeutics TTM SGA year-on-year change?

Over the past year, SMMT TTM SGA has changed by -$4.32 B (-10114.21%)